Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy activity in advanced breast cancer by circulating tumor cell subtype
2009-012738-65Phase 2Active
- Sponsor
- Azienda USL 4 Prato
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cisplatin, cyclophosphamide, gemcitabine and vinorelbine in breast cancer (2 arms), sponsored by Azienda USL 4 Prato. Primary endpoints: Time to progression and Overall survival. Started May 2009; status: active.
02
Drugs
cisplatincyclophosphamidegemcitabinevinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2009-012738-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012738-65.